JP2024538076A5 - - Google Patents
Info
- Publication number
- JP2024538076A5 JP2024538076A5 JP2024522122A JP2024522122A JP2024538076A5 JP 2024538076 A5 JP2024538076 A5 JP 2024538076A5 JP 2024522122 A JP2024522122 A JP 2024522122A JP 2024522122 A JP2024522122 A JP 2024522122A JP 2024538076 A5 JP2024538076 A5 JP 2024538076A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polynucleotide
- nucleotides
- nucleic acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254930P | 2021-10-12 | 2021-10-12 | |
| US63/254,930 | 2021-10-12 | ||
| US202263307484P | 2022-02-07 | 2022-02-07 | |
| US63/307,484 | 2022-02-07 | ||
| US202263338605P | 2022-05-05 | 2022-05-05 | |
| US63/338,605 | 2022-05-05 | ||
| PCT/US2022/046444 WO2023064388A2 (en) | 2021-10-12 | 2022-10-12 | Stereocilin promoters and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538076A JP2024538076A (ja) | 2024-10-18 |
| JP2024538076A5 true JP2024538076A5 (https=) | 2025-10-21 |
Family
ID=85988783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522122A Pending JP2024538076A (ja) | 2021-10-12 | 2022-10-12 | ステレオシリンプロモーター及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240401079A1 (https=) |
| EP (1) | EP4416294A2 (https=) |
| JP (1) | JP2024538076A (https=) |
| KR (1) | KR20240109294A (https=) |
| AU (1) | AU2022364798A1 (https=) |
| CA (1) | CA3235268A1 (https=) |
| IL (1) | IL312056A (https=) |
| MX (1) | MX2024004443A (https=) |
| WO (1) | WO2023064388A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020014625A1 (en) | 2018-07-13 | 2020-01-16 | Akouos, Inc. | Methods of treating non-syndromic sensorineural hearing loss |
| CN116836975A (zh) * | 2022-03-25 | 2023-10-03 | 上海玮美基因科技有限责任公司 | 一种耳蜗和/或前庭细胞特异性启动子及其应用 |
| WO2024250774A1 (zh) * | 2023-06-07 | 2024-12-12 | 苏州星奥拓维生物技术有限公司 | 耳蜗外毛细胞特异性启动子及其应用 |
| CN116925239B (zh) * | 2023-07-17 | 2024-10-18 | 苏州星奥拓维生物技术有限公司 | 双载体系统表达Otof基因的组合物和方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070161031A1 (en) * | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| WO2020014625A1 (en) * | 2018-07-13 | 2020-01-16 | Akouos, Inc. | Methods of treating non-syndromic sensorineural hearing loss |
| WO2020077295A1 (en) * | 2018-10-11 | 2020-04-16 | Decibel Therapeutics, Inc. | Aav1 vectors and uses thereof for treatment of otic indications |
-
2022
- 2022-10-12 EP EP22881724.3A patent/EP4416294A2/en active Pending
- 2022-10-12 CA CA3235268A patent/CA3235268A1/en active Pending
- 2022-10-12 KR KR1020247015287A patent/KR20240109294A/ko active Pending
- 2022-10-12 US US18/699,454 patent/US20240401079A1/en active Pending
- 2022-10-12 MX MX2024004443A patent/MX2024004443A/es unknown
- 2022-10-12 AU AU2022364798A patent/AU2022364798A1/en active Pending
- 2022-10-12 WO PCT/US2022/046444 patent/WO2023064388A2/en not_active Ceased
- 2022-10-12 IL IL312056A patent/IL312056A/en unknown
- 2022-10-12 JP JP2024522122A patent/JP2024538076A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024538076A5 (https=) | ||
| JP7019233B2 (ja) | ＣＲＩＳＰＲ関連タンパク質をコードする合成ポリヌクレオチドおよび合成ｓｇＲＮＡを含む組成物ならびに使用方法 | |
| JP6571075B2 (ja) | アンチセンスオリゴヌクレオチド介在性エクソンスキッピングを、それを必要とする対象の網膜において行うための方法 | |
| US12522826B2 (en) | Therapeutics for the treatment of neurodegenerative disorders | |
| AU2016202934A1 (en) | Engineered nucleic acids and methods of use thereof for non-human vertebrates | |
| JP2000500967A (ja) | 組織特異的および標的ｒｎａ特異的リボザイム | |
| WO2017109039A1 (en) | Endothelium-specific nucleic acid regulatory elements and methods and use thereof | |
| JP2024537991A5 (https=) | ||
| US20070093435A1 (en) | Modulation of cell phenotype by inhibitory rna | |
| EP4051794A1 (en) | Allele-specific silencing therapy for dfna9 using antisense oligonucleotides | |
| Reneker et al. | Chick δ1-crystallin enhancer influences mouse αA-crystallin promoter activity in transgenic mice | |
| CN102127546A (zh) | 一种骨骼肌特异性actin启动子及其应用 | |
| JP2024529108A5 (https=) | ||
| JP2025506419A5 (https=) | ||
| CN119654414A (zh) | 病毒载体 | |
| WO2022047105A2 (en) | Nucleic acids for inhibiting tert expression | |
| RU2024123834A (ru) | Регуляторные элементы gjb2 и варианты их применения | |
| US20090060889A1 (en) | Ii-RNAi involved Ii suppression in cancer immunotherapy | |
| US20230348913A1 (en) | Methods to re-engage a fetal wound healing pathway for adult skin repair | |
| CN103834660A (zh) | 一种肺组织特异性bpifa3启动子及其应用 | |
| US20260103704A1 (en) | Antisense oligonucleotides for treatment of USHER 2A. Exon 68 | |
| Xu et al. | Gene Therapy for Hereditary Hearing Loss: Comprehensive Overview and Clinical Applications | |
| JP2025524525A (ja) | Ｈｉｐｐｏシグナル伝達の遺伝子治療は、臨床的に適切なモデルにおける心臓機能を改善する | |
| HK40070836A (en) | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use | |
| RU2021105822A (ru) | Недеструктивная генная терапия для лечения mma |